or Try an Advanced Search...

    Technical Analysis for EVOK - Evoke Pharma, Inc.

    Grade Last Price % Change Price Change
    D 0.47 -10.81% -0.06
    EVOK closed down 10.81 percent on Monday, July 1, 2024, on 84 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical EVOK trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    20 DMA Resistance Bearish -10.81%
    Calm After Storm Range Contraction -10.81%
    Fell Below 20 DMA Bearish -5.92%
    MACD Bearish Signal Line Cross Bearish -5.92%
    Calm After Storm Range Contraction -5.92%
    Wide Bands Range Expansion -5.92%
    Gapped Down Weakness -5.92%
    Crossed Above 20 DMA Bullish -12.63%
    Boomer Buy Setup Bullish Swing Setup -12.63%
    Older End-of-Day Signals for EVOK ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 8 hours ago
    Down 3% about 8 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    Fell Below 10 DMA about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    EVOK Chart by TradingView
    Basic chart:

    Profile

    Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers

    Is EVOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 17 Evoke Pharma appoints Mark Kowieski as CFO
    Jun 17 Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
    May 16 Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
    May 15 Evoke Pharma GAAP EPS of -$0.17 beats by $0.04, revenue of $1.73M misses by $0.41M
    May 14 Evoke Pharma Reports First Quarter 2024 Financial Results
    Apr 17 Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
    Mar 16 Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
    Mar 15 Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
    Mar 15 Q4 2023 Evoke Pharma Inc Earnings Call
    Mar 15 Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript
    See more EVOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.4
    Average Volume 28,181
    200-Day Moving Average 0.83
    50-Day Moving Average 0.49
    20-Day Moving Average 0.53
    10-Day Moving Average 0.53
    Average True Range 0.07
    RSI (14) 45.36
    ADX 28.44
    +DI 16.90
    -DI 13.89
    Chandelier Exit (Long, 3 ATRs) 0.40
    Chandelier Exit (Short, 3 ATRs) 0.63
    Upper Bollinger Bands 0.60
    Lower Bollinger Band 0.46
    Percent B (%b) 0.07
    BandWidth 25.42
    MACD Line 0.00
    MACD Signal Line 0.01
    MACD Histogram -0.0062
    Fundamentals Value
    Market Cap 1.58 Million
    Num Shares 3.34 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -0.21
    Price-to-Sales 0.58
    Price-to-Book 1.79
    PEG Ratio -0.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.56
    Resistance 3 (R3) 0.57 0.55 0.54
    Resistance 2 (R2) 0.55 0.53 0.54 0.54
    Resistance 1 (R1) 0.51 0.51 0.50 0.50 0.53
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.45 0.47 0.44 0.44 0.41
    Support 2 (S2) 0.43 0.46 0.43 0.41
    Support 3 (S3) 0.40 0.43 0.40
    Support 4 (S4) 0.39